Outcomes After Combined Modality Therapy for EGFR-Mutant and Wild-Type Locally Advanced NSCLC

BACKGROUND. Epidermal growth factor receptor (EGFR) mutations identify a unique biological subtype of non-small cell lung cancer (NSCLC). Treatment outcomes for EGFR-mutant locally advanced NSCLC patients have not been well described. METHODS. We retrospectively examined outcomes after combined moda...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mak, Raymond H., Doran, Elizabeth, Muzikansky, Alona, Kang, Josephine, Neal, Joel W., Baldini, Elizabeth H., Choi, Noah C., Willers, Henning, Jackman, David M., Sequist, Lecia V.
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2011
Assuntos:
Lung Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3228219/
https://ncbi.nlm.nih.gov/pubmed/21632451
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0040
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados